Monday 1 February 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
George Grigoiadis
et al
. published in
Annals of Hematology
.
Read article
here
.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment